Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors.

about

Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors.

Item

http://www.wikidata.org/entity/Q42877991

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Structural optimization and ev ...... ial VEGFR-2/PDGFRβ inhibitors.

@en

Structural optimization and evaluation of novel 2-pyrrolidone-fused

@nl

type

Item

label

Structural optimization and ev ...... ial VEGFR-2/PDGFRβ inhibitors.

@en

Structural optimization and evaluation of novel 2-pyrrolidone-fused

@nl

prefLabel

Structural optimization and ev ...... ial VEGFR-2/PDGFRβ inhibitors.

@en

Structural optimization and evaluation of novel 2-pyrrolidone-fused

@nl

P1476

Structural optimization and ev ...... tial VEGFR-2/PDGFRβ inhibitors

@en

P2093

An-Rong Lee

http://www.w3.org/2001/XMLSchema#string

Chun-I Lee

http://www.w3.org/2001/XMLSchema#string

Wen-Hsin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

Tumor angiogenesis: therapeutic implications

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases

Targeting cancer with small molecule kinase inhibitors

Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor.

PDGF receptors as cancer drug targets.

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.

P2888

s13065-017-0301-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13065-017-0301-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ting-Hsuan Yang

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090936430

http://www.w3.org/2001/XMLSchema#string

P698

29086859

http://www.w3.org/2001/XMLSchema#string

P932

5539068

http://www.w3.org/2001/XMLSchema#string